![Nicole Gionet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicole Gionet
Plus aucun poste en cours
Historique de carrière de Nicole Gionet
Anciens postes connus de Nicole Gionet
Sociétés | Poste | Début | Fin |
---|---|---|---|
Atlantic Cancer Research Institute
![]() Atlantic Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services The Atlantic Cancer Research Institute is a non-profit organization which focuses on cancer research. It develops patent applications for new genetic biomarker panels for colon and prostate cancer. It provides mass spectrometry and next-generation sequencing services. It also develops protein biomarker tests to determine the presence of cancer cells in blood, urine, and stool. The company was founded in 1998 and is headquartered in Moncton, Canada. | Directeur/Membre du Conseil | - | - |
Président | - | - | |
Secrétaire Général | - | - | |
ALCATEL LUCENT | Responsable des Ressources Humaines | 19/06/2013 | - |
Statistiques
Internationale
France | 2 |
Canada | 2 |
Opérationnelle
Human Resources Officer | 1 |
Director/Board Member | 1 |
Chairman | 1 |
Sectorielle
Communications | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Alcatel-Lucent SAS
![]() Alcatel-Lucent SAS Wireless TelecommunicationsCommunications Alcatel-Lucent SAS engages in the provision of communications solutions to telecommunications companies, Internet service and data providers. It develops and integrates technologies, applications and services to offer global communications services. The company was founded in 1976 and is headquartered in Boulogne-Billancourt, France. | Communications |
Atlantic Cancer Research Institute
![]() Atlantic Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services The Atlantic Cancer Research Institute is a non-profit organization which focuses on cancer research. It develops patent applications for new genetic biomarker panels for colon and prostate cancer. It provides mass spectrometry and next-generation sequencing services. It also develops protein biomarker tests to determine the presence of cancer cells in blood, urine, and stool. The company was founded in 1998 and is headquartered in Moncton, Canada. | Commercial Services |
- Bourse
- Insiders
- Nicole Gionet
- Expérience